Is integrated transit planar portal dosimetry able to detect geometric changes in lung cancer patients treated with volumetric modulated arc therapy?

Lucas C. G. G. Persoon; Mark Podesta; Lone Hoffmann; Abir Sanizadeh; Lotte E. J. R. Schyns; Ben-Max de Ruiter; Sebastiaan M. J. J. G. Nijsten; Ludvig P. Muren; Esther G. C. Troost; Frank Verhaegen

doi:10.3109/0284186X.2015.1061213

Is integrated transit planar portal dosimetry able to detect geometric changes in lung cancer patients treated with volumetric modulated arc therapy?

Lucas C. G. G. Persoon, Mark Podesta, Lone Hoffmann, Abir Sanizadeh, Lotte E. J. R. Schyns, Ben-Max de Ruiter, Sebastiaan M. J. J. G. Nijsten, Ludvig P. Muren, Esther G. C. Troost, Frank Verhaegen^*

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

Abstract

Background. Geometric changes are frequent during the course of treatment of lung cancer patients. This may potentially result in deviations between the planned and actual delivered dose. Electronic portal imaging device (EPID)-based integrated transit planar portal dosimetry (ITPD) is a fast method for absolute in-treatment dose verification. The aim of this study was to investigate if ITPD could detect geometric changes in lung cancer patients.Materials and methods. A total of 460 patients treated with volumetric modulated arc therapy (VMAT) following daily cone beam computed tomography (CT)-based setup were visually inspected for geometrical changes on a daily basis. Forty-six patients were subject to changes and had a re-CT and an adaptive treatment plan. The reasons for adaptation were: change in atelectasis (n = 18), tumor regression (n = 9), change in pleural effusion (n = 8) or other causes (n = 11). The ITPDs were calculated on both the initial planning CT and the re-CT and compared with a global gamma () evaluation (criteria: 3%\3mm). A treatment fraction failed when the percentage of pixels failing in the radiation fields exceeded 10%. Dose-volume histograms (DVHs) were compared between the initial plan versus the plan re-calculated on the re-CT.Results. The ITPD threshold method detected 76% of the changes in atelectasis, while only 50% of the tumor regression cases and 42% of the pleural effusion cases were detected. Only 10% of the cases adapted for other reasons were detected with ITPD. The method has a 17% false-positive rate. No significant correlations were found between changes in DVH metrics and fail-rates.Conclusions. This study showed that most cases with geometric changes caused by atelectasis could be captured by ITPD, however for other causes ITPD is not sensitive enough to detect the clinically relevant changes and no predictive power of ITPD was found.

Original language	English
Pages (from-to)	1501-1507
Journal	Acta Oncologica
Volume	54
Issue number	9
DOIs	https://doi.org/10.3109/0284186X.2015.1061213
Publication status	Published - 21 Oct 2015

Access to Document

10.3109/0284186X.2015.1061213Licence: Unspecified

Cite this

Persoon, L. C. G. G., Podesta, M., Hoffmann, L., Sanizadeh, A., Schyns, L. E. J. R., de Ruiter, B.-M., Nijsten, S. M. J. J. G., Muren, L. P., Troost, E. G. C., & Verhaegen, F. (2015). Is integrated transit planar portal dosimetry able to detect geometric changes in lung cancer patients treated with volumetric modulated arc therapy? Acta Oncologica, 54(9), 1501-1507. https://doi.org/10.3109/0284186X.2015.1061213

@article{6b3f702cf68e417c9526d6601a666856,

title = "Is integrated transit planar portal dosimetry able to detect geometric changes in lung cancer patients treated with volumetric modulated arc therapy?",

abstract = "Background. Geometric changes are frequent during the course of treatment of lung cancer patients. This may potentially result in deviations between the planned and actual delivered dose. Electronic portal imaging device (EPID)-based integrated transit planar portal dosimetry (ITPD) is a fast method for absolute in-treatment dose verification. The aim of this study was to investigate if ITPD could detect geometric changes in lung cancer patients.Materials and methods. A total of 460 patients treated with volumetric modulated arc therapy (VMAT) following daily cone beam computed tomography (CT)-based setup were visually inspected for geometrical changes on a daily basis. Forty-six patients were subject to changes and had a re-CT and an adaptive treatment plan. The reasons for adaptation were: change in atelectasis (n = 18), tumor regression (n = 9), change in pleural effusion (n = 8) or other causes (n = 11). The ITPDs were calculated on both the initial planning CT and the re-CT and compared with a global gamma () evaluation (criteria: 3%\3mm). A treatment fraction failed when the percentage of pixels failing in the radiation fields exceeded 10%. Dose-volume histograms (DVHs) were compared between the initial plan versus the plan re-calculated on the re-CT.Results. The ITPD threshold method detected 76% of the changes in atelectasis, while only 50% of the tumor regression cases and 42% of the pleural effusion cases were detected. Only 10% of the cases adapted for other reasons were detected with ITPD. The method has a 17% false-positive rate. No significant correlations were found between changes in DVH metrics and fail-rates.Conclusions. This study showed that most cases with geometric changes caused by atelectasis could be captured by ITPD, however for other causes ITPD is not sensitive enough to detect the clinically relevant changes and no predictive power of ITPD was found.",

author = "Persoon, {Lucas C. G. G.} and Mark Podesta and Lone Hoffmann and Abir Sanizadeh and Schyns, {Lotte E. J. R.} and {de Ruiter}, Ben-Max and Nijsten, {Sebastiaan M. J. J. G.} and Muren, {Ludvig P.} and Troost, {Esther G. C.} and Frank Verhaegen",

year = "2015",

month = oct,

day = "21",

doi = "10.3109/0284186X.2015.1061213",

language = "English",

volume = "54",

pages = "1501--1507",

journal = "Acta Oncologica",

issn = "0284-186X",

publisher = "Routledge/Taylor & Francis Group",